Dr. Woods’ research focuses on translational cardiovascular diseases. He investigates novel therapies for supraventricular tachycardia, atrial fibrillation, and ventricular tachycardia, as well as stroke prevention. These include investigator-initiated and industry-supported clinical trials in the focus areas described above.
Dr. Woods received an M.D. and Ph.D. from the University of California at Los Angeles through the NIH Medical Scientist Training Program. He completed residency training in internal medicine at Stanford University as part of the clinical investigator pathway, fellowship and chief fellowship in cardiology also at Stanford, and clinical cardiac electrophysiology fellowship at the University of California at San Francisco.
Sutter Health Research Enterprise
1100 Van Ness Ave.
5th Floor
San Francisco, CA, 94109
(650) 652-8600
clinicalresearch@sutterhealth.org
Primary Research Interests
Related Clinical Trials
CONVERGE PAS (AtriCure)
Investigators: Tomomi Oka M.D., Amir Schricker M.D., M.S., FACC, FHRS, Christopher Woods, M.D. Ph.D., FHRS
Status: Active, Recruiting
Integra D (Coming Soon)
Investigators: Nancy Luo MD, Christopher Woods, M.D. Ph.D., FHRS
Option
Investigator: Christopher Woods, M.D. Ph.D., FHRS
Status: Active, Not Recruiting
Persistent Afib (Coming Soon)
Investigator: Christopher Woods, M.D. Ph.D., FHRS
VOLT AF
Investigators: Amir Schricker M.D., M.S., FACC, FHRS, Christopher Woods, M.D. Ph.D., FHRS
Status: Active, Not Recruiting